Runnymede Capital Advisors, Inc. Zoetis Inc. Transaction History
Runnymede Capital Advisors, Inc.
- $114 Billion
- Q4 2024
A detailed history of Runnymede Capital Advisors, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Runnymede Capital Advisors, Inc. holds 23 shares of ZTS stock, worth $4,008. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23Holding current value
$4,008% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ZTS
# of Institutions
1,984Shares Held
414MCall Options Held
1MPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA41.4MShares$7.21 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.42 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.45 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.8 Billion2.73% of portfolio
-
Alliancebernstein L.P. New York, NY15.4MShares$2.68 Billion1.05% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $81.6B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...